Home — Nuffield Department of Medicine

Protect our community. Protect the vulnerable. Protect yourself.

Pandemic preparedness - ISARIC

ISARIC’s pre-positioned ‘epidemic’ research protocols were used to publish the first clinical report of COVID19 in Wuhan in January 2020.

National serology testing and decision-making

NDM has created a high throughput robotic serology testing platform reporting anti-SARS-2 Spike antibody levels in people exposed to the virus (>99% sensitivity and specificity).

Oxford vaccine: individual and herd immunity

Professor Gilbert has adapted her ChAdOx1 vector vaccine to express the SARS-CoV-2 spike protein. The Jenner Team continue impressive work on research trials.

Holding back the tide - Mobile Phone Apps

Digital contact tracing with mobile phones could play a role in helping to contain the epidemic spread of the SARS-COV-2 virus.

Drug Trials - RECOVERY

RECOVERY was rapidly embedded across the NHS, and it has become the largest randomised control trial looking at potential treatments for treatment in COVID-19 in hospitalised patients worldwide.

Anti-viral drug discovery

A newly formed UK wide COVID-19 Protein Production Consortium (CPPC), have worked to create, characterise and distribute a wide variety of SARS-Cov-2 viral proteins for the purposes of drug screens.

Antibody and nanobody therapeutics

Groups across NDM have rapidly mapped out immune responses to SARS-CoV-2.

Pathology of COVID19 disease - clues to future treatment

NDM is prioritising new paradigms of molecular pathology that explore disease at the levels of cells and their relationships, they key to future treatment of COVID-19.

About

Welcome to the Nuffield Department of Medicine. We are a thriving and multi-disciplinary community of scientists based in Oxford and abroad with many partnerships in other universities, institutions, and industry. Richard Cornall is the Nuffield Professor of Clinical Medicine.

DPhil in Clinical Medicine Applications now open!

Fully funded PhD studentships are available to outstanding candidates.

World’s largest clinical trial for COVID-19 treatments expands internationally

18 February 2021

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

15 February 2021

More news

Meet our researchers

PUBLIC INVOLVEMENT

Engaging the public with research helps empower people, broadens attitudes to academic research, and ensures that the work we do is relevant to society and its wider social concerns.

INSTITUTES, CENTRES & UNITS